SCHEMBL20155115

SCHEMBL20155115

Cn1cc(Br)c2nn(Cc3ccccc3)cc2c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 5/20 0.50
BRD4 O60885 7/20 0.46
PDE4A P27815 3/20 0.42
PDE4B Q07343 3/20 0.42
PDE4C Q08493 3/20 0.42
PDE4D Q08499 3/20 0.42
PDE3B Q13370 3/20 0.42
PDE3A Q14432 3/20 0.42
PARP1 P09874 1/20 0.41
CREBBP Q92793 1/20 0.41
ADORA2A P29274 2/20 0.39
ADORA1 P30542 2/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20155118 0.79 NPC1 (0.40) BRD4ALDH1A1KDM4EMEN1KMT2A
SCHEMBL20155616 0.77 ALDH1A1 (0.38) ADORA3BRD4PDE4APDE4BPDE4C
SCHEMBL29455896 0.75 ADORA3 (0.45) ADORA3BRD4PDE4APDE4BPDE4C
SCHEMBL20155109 0.75 ADORA3 (0.56) ADORA3PARP1ADORA2AADORA1ALDH1A1
SCHEMBL20155045 0.74 ALDH1A1 (0.39) BRD4ALDH1A1CYP1A2KDM4EMEN1
SCHEMBL20155529 0.74 CNR2 (0.40) BRD4ALDH1A1KDM4EMEN1LMNA
SCHEMBL20155003 0.72 BRD4 (0.36) BRD4ADORA2AADORA1NPSR1
SCHEMBL15554968 0.69 NPC1 (0.44) ADORA3ADORA2AADORA1ALDH1A1NPSR1
SCHEMBL20154927 0.69 MAT2A (0.40) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL1169735 0.69 HDAC8 (0.49) ADORA3PARP1ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018086604-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATIONS THEREOF 山东罗欣药业集团股份有限公司 2018-05-17 WO disclosed